FilingFirehose · free AI preview
Entrada Therapeutics, Inc.
TRDA · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Entrada Therapeutics (TRDA) filed a Form 8-K on June 10, 2026 disclosing an officer departure, flagged under Item 5.02. Our 90-day window detected one red-flag filing with no cyber incidents. The departure context, combined with the company's capital structure and recent financing activity, requires deeper analysis to assess ongoing execution risk. The full $49 Report adds dilution modeling, 12-month filing history, financing trajectory, and AI-detected risk signals across SEC filings.
Want the full 5-section $49 Report on TRDA?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.